CoChat

Structure and Function of Human DnaJ Homologue Subfamily A Member 1 (DNAJA1) and Its Relationship to Pancreatic Cancer

Stark, Jaime L., Mehla, Kamiya, Chaika, Nina, Acton, Thomas B., Xiao, Rong, Singh, Pankaj K., Montelione, Gaetano T., Powers, Robert · 2014 · Biochemistry
Cited by 58

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Pancreatic cancer has a dismal 5 year survival rate of 5.5% that has not been improved over the past 25 years despite an enormous amount of effort. Thus, there is an urgent need to identify truly novel yet druggable protein targets for drug discovery. The human protein DnaJ homologue subfamily A member 1 (DNAJA1) was previously shown to be downregulated 5-fold in pancreatic cancer cells and has been targeted as a biomarker for pancreatic cancer, but little is known about the specific biological function for DNAJA1 or the other members of the DnaJ family encoded in the human genome. Our results suggest the overexpression of DNAJA1 suppresses the stress response capabilities of the oncogenic transcription factor, c-Jun, and results in the diminution of cell survival. DNAJA1 likely activates a DnaK protein by forming a complex that suppresses the JNK pathway, the hyperphosphorylation of c-Jun, and the anti-apoptosis state found in pancreatic cancer cells. A high-quality nuclear magnetic resonance solution structure of the J-domain of DNAJA1 combined with a bioinformatics analysis and a ligand affinity screen identifies a potential DnaK binding site, which is also predicted to overlap with an inhibitory binding site, suggesting DNAJA1 activity is highly regulated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/bi401329a

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 87

  1. Siegel, 2012, Cancer statistics, 2012, Ca-Cancer J. Clin., 62, 10, 10.3322/caac.20138 · DOI · Paper page
  2. Li, 2004, Pancreatic cancer, Lancet, 363, 1049, 10.1016/S0140-6736(04)15841-8 · DOI · Paper page
  3. Hidalgo, 2012, New insights into pancreatic cancer biology, Ann. Oncol., 23, x135, 10.1093/annonc/mds313 · DOI
  4. Sheikh, 2010, Challenges of drug resistance in the management of pancreatic cancer, Expert Rev. Anticancer Ther., 10, 1647, 10.1586/era.10.148 · DOI
  5. Rivera, 2009, Treatment of advanced pancreatic cancer: From gemcitabine single agent to combinations and targeted therapy, Cancer Treat. Rev., 35, 335, 10.1016/j.ctrv.2008.11.007 · DOI
  6. Jiang, 2007, Structural basis of J cochaperone binding and regulation of Hsp70, Mol. Cell, 28, 422, 10.1016/j.molcel.2007.08.022 · DOI · Paper page
  7. Mitra, 2009, Multi-faceted role of HSP40 in cancer, Clin. Exp. Metastasis, 26, 559, 10.1007/s10585-009-9255-x · DOI
  8. Qiu, 2006, The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones, Cell. Mol. Life Sci., 63, 2560, 10.1007/s00018-006-6192-6 · DOI · Paper page
  9. Horne, 2010, The Hsp40 J-domain stimulates Hsp70 when tethered by the client to the ATPase domain, J. Biol. Chem., 285, 21679, 10.1074/jbc.M110.113118 · doi:10.1074/jbc.m110.113118
  10. Wall, 1994, The NH2-terminal 108 amino acids of the Escherichia coli DnaJ protein stimulate the ATPase activity of DnaK and are sufficient for lambda replication, J. Biol. Chem., 269, 5446, 10.1016/S0021-9258(17)37706-2 · DOI · Paper page
  11. Walsh, 2004, The J-protein family: Modulating protein assembly, disassembly and translocation, EMBO Rep., 5, 567, 10.1038/sj.embor.7400172 · DOI · Paper page
  12. Terada, 2010, Multiple molecules of Hsc70 and a dimer of DjA1 independently bind to an unfolded protein, J. Biol. Chem., 285, 16789, 10.1074/jbc.M110.101501 · DOI
  13. Terada, 2005, A type I DnaJ homolog, DjA1, regulates androgen receptor signaling and spermatogenesis, EMBO J., 24, 611, 10.1038/sj.emboj.7600549 · DOI
  14. Wang, 2006, HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway, Cancer Res., 66, 6756, 10.1158/0008-5472.CAN-06-0185 · DOI · Paper page
  15. Chow, 2008, A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors, Cancer Chemother. Pharmacol., 62, 631, 10.1007/s00280-007-0646-x · DOI
  16. Patnaik, 2003, A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies, Clin. Cancer Res., 9, 4761
  17. Crnogorac-Jurcevic, 2005, Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma, Gastroenterology, 129, 1454, 10.1053/j.gastro.2005.08.012 · DOI · Paper page
  18. Kanazawa, 1997, HSDJ, a human homolog of DnaJ, is farnesylated and is involved in protein import into mitochondria, J. Biochem., 121, 890, 10.1093/oxfordjournals.jbchem.a021670 · DOI
  19. Terada, 1997, The human DnaJ homologue dj2 facilitates mitochondrial protein import and luciferase refolding, J. Cell Biol., 139, 1089, 10.1083/jcb.139.5.1089 · DOI
  20. Llambi, 2011, Apoptosis and oncogenesis: Give and take in the BCL-2 family, Curr. Opin. Genet. Dev., 21, 12, 10.1016/j.gde.2010.12.001 · DOI · Paper page
  21. Ott, 2007, Mitochondria, oxidative stress and cell death, Apoptosis, 12, 913, 10.1007/s10495-007-0756-2 · DOI · Paper page
  22. Paschen, 2007, Mitochondrial protein import: A matter of death?, Cell Cycle, 6, 2434, 10.4161/cc.6.20.4780 · doi:10.4161/cc.6.20.4780
  23. Petit, 2009, The mitochondrial outer membrane protein import machinery: A new player in apoptosis?, Front. Biosci., 14, 3563, 10.2741/3471 · DOI
  24. Gurbuxani, 2001, Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells, Oncogene, 20, 7478, 10.1038/sj.onc.1204948 · DOI
  25. Jaattela, 1995, Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells, Int. J. Cancer, 60, 689, 10.1002/ijc.2910600520 · DOI · Paper page
  26. Jaattela, 1992, Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity, EMBO J., 11, 3507, 10.1002/j.1460-2075.1992.tb05433.x · DOI · Paper page
  27. Jaattela, 1998, Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases, EMBO J., 17, 6124, 10.1093/emboj/17.21.6124 · DOI · Paper page
  28. Rohde, 2005, Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms, Genes Dev., 19, 570, 10.1101/gad.305405 · DOI · Paper page
  29. Volloch, 1999, Oncogenic potential of Hsp72, Oncogene, 18, 3648, 10.1038/sj.onc.1202525 · doi:10.1038/sj.onc.1202525
  30. McDermott, 2001, Overexpression of MUC1 reconfigures the binding properties of tumor cells, Int. J. Cancer, 94, 783, 10.1002/ijc.1554 · DOI
  31. Singh, 2007, Platelet-derived growth factor receptor β-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells, Cancer Res., 67, 5201, 10.1158/0008-5472.CAN-06-4647 · DOI · Paper page
  32. Singh, 2008, Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression, J. Biol. Chem., 283, 26985, 10.1074/jbc.M805036200 · DOI
  33. Wen, 2003, Nuclear association of the cytoplasmic tail of MUC1 and β-catenin, J. Biol. Chem., 278, 38029, 10.1074/jbc.M304333200 · DOI · Paper page
  34. Costa, 2011, Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line, PLoS One, 6, e26970, 10.1371/journal.pone.0026970 · doi:10.1371/journal.pone.0026970
  35. Acton, 2011, Preparation of protein samples for NMR structure, function, and small-molecule screening studies, Methods Enzymol., 493, 21, 10.1016/B978-0-12-381274-2.00002-9 · DOI · Paper page
  36. Xiao, 2010, The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium, J. Struct. Biol., 172, 21, 10.1016/j.jsb.2010.07.011 · DOI · Paper page
  37. Bax, 2011, Triple resonance three-dimensional protein NMR: Before it became a black box, J. Magn. Reson., 213, 442, 10.1016/j.jmr.2011.08.003 · doi:10.1016/j.jmr.2011.08.003
  38. Ikura, 1990, A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: Heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin, Biochemistry, 29, 4659, 10.1021/bi00471a022 · DOI · Paper page
  39. Kay, 2011, Three-dimensional triple-resonance NMR spectroscopy of isotopically enriched proteins. 1990, J. Magn. Reson., 213, 423, 10.1016/j.jmr.2011.09.004 · DOI · Paper page
  40. Delaglio, 1995, NMRPipe: A multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR, 6, 277, 10.1007/BF00197809 · DOI · Paper page
  41. Vranken, 2005, The CCPN data model for NMR spectroscopy: Development of a software pipeline, Proteins, 59, 687, 10.1002/prot.20449 · DOI · Paper page
  42. Bonvin, 2010, The eNMR platform for structural biology, J. Struct. Funct. Genomics, 11, 1, 10.1007/s10969-010-9084-9 · DOI
  43. Shen, 2009, De novo protein structure generation from incomplete chemical shift assignments, J. Biomol. NMR, 43, 63, 10.1007/s10858-008-9288-5 · DOI · Paper page
  44. Schwieters, 2003, The Xplor-NIH NMR molecular structure determination package, J. Magn. Reson., 160, 65, 10.1016/S1090-7807(02)00014-9 · DOI · Paper page
  45. Shen, 2009, TALOS+: A hybrid method for predicting protein backbone torsion angles from NMR chemical shifts, J. Biomol. NMR, 44, 213, 10.1007/s10858-009-9333-z · DOI · Paper page
  46. Nederveen, 2005, RECOORD: A recalculated coordinate database of 500+ proteins from the PDB using restraints from the BioMagResBank, Proteins, 59, 662, 10.1002/prot.20408 · DOI · Paper page
  47. Huang, 2005, Protein NMR Recall, Precision, and F-measure Scores (RPF Scores): Structure Quality Assessment Measures Based on Information Retrieval Statistics, J. Am. Chem. Soc., 127, 1665, 10.1021/ja047109h · DOI · Paper page
  48. Bhattacharya, 2007, Evaluating protein structures determined by structural genomics consortia, Proteins, 66, 778, 10.1002/prot.21165 · DOI · Paper page
  49. Eisenberg, 1997, VERIFY3D: Assessment of protein models with three-dimensional profiles, Methods Enzymol., 277, 396, 10.1016/S0076-6879(97)77022-8 · DOI · Paper page
  50. Sippl, 1993, Recognition of errors in three-dimensional structures of proteins, Proteins, 17, 355, 10.1002/prot.340170404 · DOI · Paper page
  51. Laskowski, 1993, PROCHECK: A program to check the stereochemical quality of protein structures, J. Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944 · DOI · Paper page
  52. Davis, 2007, MolProbity: All-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Res., 35, W375, 10.1093/nar/gkm216 · DOI · Paper page
  53. Pettersen, 2004, UCSF Chimera: A visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  54. Thompson, 2002, Multiple sequence alignment using ClustalW and ClustalX
  55. Pellecchia, 1996, NMR structure of the J-domain and the Gly/Phe-rich region of the Escherichia coli DnaJ chaperone, J. Mol. Biol., 260, 236, 10.1006/jmbi.1996.0395 · DOI · Paper page
  56. Qian, 1996, Nuclear magnetic resonance solution structure of the human Hsp40 (HDJ-1) J-domain, J. Mol. Biol., 260, 224, 10.1006/jmbi.1996.0394 · DOI
  57. Gao, 2012, The C-terminal helices of heat shock protein 70 are essential for J-domain binding and ATPase activation, J. Biol. Chem., 287, 6044, 10.1074/jbc.M111.294728 · DOI
  58. Honig, 1995, Classical electrostatics in biology and chemistry, Science, 268, 1144, 10.1126/science.7761829 · DOI · Paper page
  59. Ashkenazy, 2010, ConSurf 2010: Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids, Nucleic Acids Res., 38, W529, 10.1093/nar/gkq399 · DOI · Paper page
  60. Mercier, 2006, Design and characterization of a functional library for NMR screening against novel protein targets, Comb. Chem. High Throughput Screening, 9, 515, 10.2174/138620706777935342 · doi:10.2174/138620706777935342
  61. Mercier, 2005, Determining the optimal size of small molecule mixtures for high throughput NMR screening, J. Biomol. NMR, 31, 243, 10.1007/s10858-005-0948-4 · DOI
  62. Mercier, 2006, FAST-NMR: Functional annotation screening technology using NMR spectroscopy, J. Am. Chem. Soc., 128, 15292, 10.1021/ja0651759 · doi:10.1021/ja0651759
  63. Powers, 2008, The application of FAST-NMR for the identification of novel drug discovery targets, Drug Discovery Today, 13, 172, 10.1016/j.drudis.2007.11.001 · DOI
  64. Garrett, 1997, Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system, Biochemistry, 36, 4393, 10.1021/bi970221q · DOI · Paper page
  65. Morris, 1998, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J. Comput. Chem., 19, 1639, 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B · doi:10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
  66. Morris, 2009, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J. Comput. Chem., 30, 2785, 10.1002/jcc.21256 · DOI · Paper page
  67. Sanner, 1999, Python: A programming language for software integration and development, J. Mol. Graphics Modell., 17, 57
  68. Stark, 2008, Rapid protein-ligand costructures using chemical shift perturbations, J. Am. Chem. Soc., 130, 535, 10.1021/ja0737974 · DOI
  69. Chen, 2000, The c-Jun N-terminal kinase pathway and apoptotic signaling (review), Int. J. Oncol., 16, 651
  70. Shaulian, 2010, AP-1─The Jun proteins: Oncogenes or tumor suppressors in disguise?, Cell. Signalling, 22, 894, 10.1016/j.cellsig.2009.12.008 · DOI · Paper page
  71. Wisdom, 1999, c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms, EMBO J., 18, 188, 10.1093/emboj/18.1.188 · DOI · Paper page
  72. Ahmed, 2009, Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network, PLoS One, 4, e7305, 10.1371/journal.pone.0007305 · DOI
  73. Eferl, 2003, Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53, Cell, 112, 181, 10.1016/S0092-8674(03)00042-4 · DOI · Paper page
  74. Agarwal, 1995, Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: Activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways, Oncogene, 11, 427
  75. Binetruy, 1991, Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain, Nature, 351, 122, 10.1038/351122a0 · DOI · Paper page
  76. Wodrich, 1993, Overexpression of oncoproteins in non-small cell lung carcinomas of smokers, Carcinogenesis, 14, 1121, 10.1093/carcin/14.6.1121 · DOI
  77. Shin, 2009, Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism, Mol. Cancer Res., 7, 745, 10.1158/1541-7786.MCR-08-0462 · DOI
  78. Tessari, 1999, The expression of proto-oncogene c-jun in human pancreatic cancer, Anticancer Res., 19, 863
  79. Jolly, 2000, Role of the heat shock response and molecular chaperones in oncogenesis and cell death, J. Natl. Cancer Inst., 92, 1564, 10.1093/jnci/92.19.1564 · DOI · Paper page
  80. Mosser, 2000, The chaperone function of hsp70 is required for protection against stress-induced apoptosis, Mol. Cell. Biol., 20, 7146, 10.1128/MCB.20.19.7146-7159.2000 · DOI · Paper page
  81. Takayama, 2003, Heat-shock proteins as regulators of apoptosis, Oncogene, 22, 9041, 10.1038/sj.onc.1207114 · DOI · Paper page
  82. Sousa, 2012, Evaluation of competing J domain:Hsp70 complex models in light of existing mutational and NMR data, Proc. Natl. Acad. Sci. U.S.A., 109, E734, 10.1073/pnas.1120597109 · doi:10.1073/pnas.1120597109
  83. Ahmad, 2011, Heat shock protein 70 kDa chaperone/DnaJ cochaperone complex employs an unusual dynamic interface, Proc. Natl. Acad. Sci. U.S.A., 108, 18966, 10.1073/pnas.1111220108 · DOI · Paper page
  84. Zuiderweg, 2012, Reply to Sousa et al.: Evaluation of competing J domain:Hsp70 complex models in light of methods used, Proc. Natl. Acad. Sci. U.S.A., 109, E735, 10.1073/pnas.1121554109 · doi:10.1073/pnas.1121554109
  85. Greene, 1998, Role of the J-domain in the cooperation of Hsp40 with Hsp70, Proc. Natl. Acad. Sci. U.S.A., 95, 6108, 10.1073/pnas.95.11.6108 · DOI · Paper page
  86. Mokranjac, 2003, Tim14, a novel key component of the import motor of the TIM23 protein translocase of mitochondria, EMBO J., 22, 4945, 10.1093/emboj/cdg485 · DOI · Paper page
  87. Mokranjac, 2006, Structure and function of Tim14 and Tim16, the J and J-like components of the mitochondrial protein import motor, EMBO J., 25, 4675, 10.1038/sj.emboj.7601334 · DOI

Cited by

See all 58

Metadata

Authors
Stark, J. L., Mehla, K., Chaika, N., Acton, T. B., Xiao, R., Singh, P. K., Montelione, G. T., & Powers, R.
Venue
Biochemistry
Published
2014-02-10
Volume
53
Issue
8
Pages
1360-1372
ISSN
  • 0006-2960
  • 1520-4995
Cited by
58
References
7
Language
en
Funders
NIH Office of the Director (P50 CA127297, R01 CA163649, R21 AI081154, RR015468-01, U54 CA163120, U54 GM094597)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure and Function of Human DnaJ Homologue Subfamily A Member 1 (DNAJA1) and Its Relationship to Pancreatic Cancer. https://app.cochat.ai/papers/10.1021/bi401329a
The paper
Stark, J. L., Mehla, K., Chaika, N., Acton, T. B., Xiao, R., Singh, P. K., Montelione, G. T., & Powers, R. (2014). Structure and Function of Human DnaJ Homologue Subfamily A Member 1 (DNAJA1) and Its Relationship to Pancreatic Cancer. Biochemistry. https://doi.org/10.1021/bi401329a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.